IMCT-04TOCA 5: PHASE 2/3 RANDOMIZED, OPEN-LABEL STUDY OF TOCA 511 WITH TOCA FC VERSUS STANDARD OF CARE IN PATIENTS UNDERGOING PLANNED RESECTION FOR RECURRENT HIGH GRADE GLIOMA (NCT02414165)

A phase 2, open-label study of niraparib in women with advanced, relapsed, high-grade serous epithelial ovarian, fallopian tube or primary peritoneal cancer after ≥3 previous chemotherapy regimens.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.tps5609 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. TPS5609-TPS5609 ◽

Author(s):

Kathleen N. Moore ◽

Bj Rimel ◽

Shefali Agarwal ◽

John Balser ◽

Robert E. Martell ◽

...

Keyword(s):

Fallopian Tube ◽

High Grade ◽

Phase 2 ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer

monarcHER: A phase 2 randomized open-label study of abemaciclib plus trastuzumab (T) with or without fulvestrant (F) compared to standard-of-care chemotherapy of physician's choice plus T in women with HR +, HER2+ advanced breast cancer

Annals of Oncology ◽

10.1093/annonc/mdw365.93 ◽

2016 ◽

Vol 27 ◽

pp. vi99 ◽

Author(s):

S.M. Tolaney ◽

N. Bourayou ◽

S. Goel ◽

T. Forrester ◽

F. André

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Standard Of Care ◽

Advanced Breast ◽

Phase 2 ◽

Open Label ◽

Open Label Study ◽

Abstract CT107: A PHASE 1B/2 OPEN-LABEL STUDY WITH RANDOMIZATION IN PHASE 2 OF IMU-131 HER2/NEU PEPTIDE VACCINE PLUS STANDARD OF CARE CHEMOTHERAPY IN PATIENTS WITH HER2/NEU OVEREXPRESSING METASTATIC OR ADVANCED ADENOCARCINOMA OF THE STOMACH OR GASTROESOPHAGEAL JUNCTION

10.1158/1538-7445.am2021-ct107 ◽

2021 ◽

Author(s):

Marina Maglakelidze ◽

Dinara Ryspayeva ◽

Iurie Bulat ◽

Zoran Andric ◽

Ivan Nikolic ◽

...

Keyword(s):

Gastroesophageal Junction ◽

Peptide Vaccine ◽

Standard Of Care ◽

Phase 2 ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Phase 1B

Faculty Opinions recommendation of Neridronate improves bone mineral density and reduces back pain in β-thalassaemia patients with osteoporosis: results from a phase 2, randomized, parallel-arm, open-label study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717797810.793153212 ◽

2012 ◽

Author(s):

Klaus Klaushofer

Keyword(s):

Bone Mineral Density ◽

Back Pain ◽

Bone Mineral ◽

Phase 2 ◽

Mineral Density ◽

Open Label ◽

Open Label Study ◽

Results of a phase 2, multicenter, single‐arm, open‐label study of lenalidomide in pediatric patients with relapsed or refractory acute myeloid leukemia

Pediatric Blood & Cancer ◽

10.1002/pbc.28946 ◽

2021 ◽

Author(s):

Maureen M. O'Brien ◽

Todd A. Alonzo ◽

Todd M. Cooper ◽

John E. Levine ◽

Patrick A. Brown ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

Pediatric Patients ◽

Phase 2 ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Refractory Acute Myeloid Leukemia ◽

Acute Myeloid

Gemcitabine, cisplatin, and dexamethasone (GDP) in combination with methotrexate and pegaspargase is active in newly diagnosed peripheral T cell lymphoma patients: a phase 2, single-center, open-label study in China

Annals of Hematology ◽

10.1007/s00277-018-3488-1 ◽

2018 ◽

Vol 98 (1) ◽

pp. 143-150 ◽

Author(s):

Yan Zhang ◽

Wei Zhang ◽

Jian Li ◽

Minghui Duan ◽

Bing Han ◽

...

Keyword(s):

T Cell ◽

Cell Lymphoma ◽

T Cell Lymphoma ◽

Phase 2 ◽

Newly Diagnosed ◽

Single Center ◽

Open Label ◽

Peripheral T Cell Lymphoma ◽

Open Label Study ◽

Abstract OT-32-01: A phase 2, open-label study of bintrafusp alfa monotherapy in patients withHMGA2-expressing triple-negative breast cancer

10.1158/1538-7445.sabcs20-ot-32-01 ◽

2021 ◽

Author(s):

Leisha A Emens ◽

Margaret E. Gatti-Mays ◽

Joyce O’Shaughnessy ◽

Luc Dirix ◽

Giovanni Faggioni ◽

...

Keyword(s):

Breast Cancer ◽

Triple Negative Breast Cancer ◽

Triple Negative ◽

Phase 2 ◽

Open Label ◽

Open Label Study ◽

O-11 Trastuzumab deruxtecan (T-DXd; DS-8201) in patients with HER2-positive advanced gastric or gastroesophageal junction adenocarcinoma: A randomized, phase 2, multicenter, open-label study (DESTINY-Gastric01)

Annals of Oncology ◽

10.1016/j.annonc.2020.04.064 ◽

2020 ◽

Vol 31 ◽

pp. 235

Author(s):

K. Yamaguchi ◽

Y. Bang ◽

S. Iwasa ◽

N. Sugimoto ◽

M. Ryu ◽

...

Keyword(s):

Gastroesophageal Junction ◽

Phase 2 ◽

Her2 Positive ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Gastroesophageal Junction Adenocarcinoma ◽

O 11 ◽

Randomized Phase 2

The Herby Study: a Phase 2 Open-Label, Randomized, Multicenter Study of Bevacizumab-Based Therapy in Pediatric Patients with Newly Diagnosed High-Grade Glioma

Annals of Oncology ◽

10.1093/annonc/mdu330.27 ◽

2014 ◽

Vol 25 ◽

pp. iv145

Author(s):

J. Grill ◽

D. Hargrave ◽

P. Varlet ◽

T. Jaspan ◽

C. Jones ◽

...

Keyword(s):

Multicenter Study ◽

Pediatric Patients ◽

High Grade Glioma ◽

High Grade ◽

Phase 2 ◽

Newly Diagnosed ◽

Open Label

A Phase 2 Randomized Open-Label Study of Ramucirumab (IMC 1121b; RAM) in Combination with Platinum-Based Chemotherapy in Patients (PTS) with Recurrent or Advanced Non-Small Cell Lung Cancer (NSCLC): Results From Non-Squamous (NSQ) PTS (NCT01160744)

Annals of Oncology ◽

10.1016/s0923-7534(20)33839-4 ◽

2012 ◽

Vol 23 ◽

pp. ix408 ◽

Author(s):

R. Doebele ◽

D. Spigel ◽

M. Tehfe ◽

S. Thomas ◽

M. Reck ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase 2 ◽

Small Cell Lung ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Platinum Based Chemotherapy